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Traditional Chinese Medicine (TCM) has a 3000 years’ history of human use. A literature survey addressing traditional evidence
from human studies was done, with key result that top 10 TCM herb ingredients including Poria cocos, Radix polygalae, Radix
glycyrrhizae, Radix angelica sinensis,a n dRadix rehmanniae were prioritized for highest potential beneﬁt to dementia intervention,
related to the highest frequency of use in 236 formulae collected from 29 ancient Pharmacopoeias, ancient formula books, or
historical archives on ancient renowned TCM doctors, over the past 10 centuries. Based on the history of use, there was strong
clinicalsupportthatRadixpolygalaeismemoryimproving.Pharmacologicalinvestigationalsoindicatedthatalltheﬁveingredients
mentioned above can elicit memory-improving eﬀects in vivo and in vitro via multiple mechanisms of action, covering estrogen-
like, cholinergic, antioxidant, anti-inﬂammatory, antiapoptotic, neurogenetic, and anti-Aβ activities. Furthermore, 11 active
principles were identiﬁed, including sinapic acid, tenuifolin, isoliquiritigenin, liquiritigenin, glabridin, ferulic acid, Z-ligustilide,
N-methyl-beta-carboline-3-carboxamide, coniferyl ferulate and 11-angeloylsenkyunolide F, and catalpol. It can be concluded
that TCM has a potential for complementary and alternative role in treating senile dementia. The scientiﬁc evidence is being
continuously mined to back up the traditional medical wisdom.
1.Introduction
Cognitive impairment or dementia in elderly is associated
with many disorders [1]. Alzheimer’s disease (AD) is the
principal type of dementia and represents about 70% of the
dementia patients.
The pathologic hallmarks of AD are senile plaques,
neuroﬁbrillary tangles, dystrophic neurites, and neuronal
loss. The development of AD may be due to the improper
biochemical processing of amyloid precursor protein (APP)
leading to subsequent accumulation of β-amyloid (Aβ). The
amyloid and tangle cascade hypothesis is the dominant
explanation for the pathogenesis of AD [2]. Other relevant
factors, including cholinergic dysfunction [3], neuroinﬂam-
mation [4, 5], oxidative stress [6], and disturbance of
neuronal plasticity [7], age-related loss of sex hormones
[8, 9], are important and contribute to the understanding of
AD pathology.
The 2nd most common form of dementia is vascular
dementia (VD) or multi-infarct dementia, which accounts
for about 15% of dementia cases [10, 11]. VD may fol-
low after a succession of acute cerebrovascular events or,
less commonly, a single major stroke. The compromised
cerebrovascular circulation causes ischemia that leads to
damage of the brain structure, for example, formation of
white matter lesions or silent brain infarctions. VD is often
related to the loss of ﬁne motor control besides memory
impairment.
Currently, there is no eﬀective treatment for AD,
although many treatment strategies exist [12]. Clinically,
cholinesterase inhibitors (ChEIs) and N-methyl-D-aspartate
(NMDA) receptor antagonists are ﬁrst-line pharmacother-
apy for mild-to-moderate AD, with high nonresponse rate
50–75% [13].
Lots of folk plants in traditional medicine are being used
in age-related brain disorders for improvement of memory
and cognitive function [14–16]. In China, a number of
herb ingredients known from Traditional Chinese Medicine
(TCM) have a long history of use for mental health. In this
study, we exploited the empirically driven TCM lore and
surveyed scientiﬁc data to back up the cognitive beneﬁts,
claimed by TCM.2 Evidence-Based Complementary and Alternative Medicine
2. Ancient Records on TCM for
Cognitive Decline
The term “senile dementia” refersto a clinical syndrome seen
in the elderly characterized by impairment of memory and
cognition. So in a search of the ancient literature of TCM,
the etiology, pathogenesis, and treatment for “dementia or
amnesia” have been used for the survey in detail.
2.1. Etiology and Pathogenesis
2.1.1. Deﬁciency of Energy. Deﬁciency of energy is similar
to “Qi” deﬁciency in TCM. According TCM lore Qi is the
essential substance that makes up the body and maintains
various physiological activities, similar to ﬂow of energy
in the body. The energy is mainly from the kidney, heart,
and spleen, especially from the kidney. In TCM, the energy
from the kidney is called kidney essence which can produce
marrow including cerebral marrow, spinal cord, and bone
marrow. The cerebral marrow can nourish the brain and
maintain the physiological functions of the brain. If the
kidney essence is insuﬃcient, the production of cerebral
marrow will be reduced, leading to various symptoms, such
as headache, dizziness, amnesia, and retard response [17].
2.1.2. Blood Stasis. Normally the blood is pumped by the
heart to ﬂow in the vessels. If blood circulation is stagnated
or slowed down by certain factors such as cold, emotional
disorder, aging, consumptive disease, and overstrain, it
will result in retention of blood ﬂow in the vessels or
organs, a pathological condition named blood stasis. The
cognitive function will decline, due to long-term global
hypo-perfusion in cerebral blood ﬂow or acute focal stroke
in memory-related cerebral parenchyma [17].
2.1.3. Toxin. As the function of internal organs in the elderly
decline, the balance between host defense and external
toxins in the body is disrupted. Pathological or physiological
products occur and form toxin including waste of “water”
and “endogenous ﬁre”, which result from the poor digestion,
accumulates into phlegm and retention of ﬂuid, and caused
by mental disorder, attack from pathological factors, and
imbalance within the body, respectively. If such toxins can
not be eliminated quickly the blood circulation and mental
acuity will be aﬀected, eventually contributing to the onset
of dementia.
2.2. Therapy of TCM. TCM has a long history for preventing
and treating cognitive decline. Although AD is a modern
disease entity and has no direct analogue in the ancient
Chinese medicine literature, disorders of memory and
cognitive deﬁcit are referred to throughout the classical
literature. For example, in Sheng Nong Ben Cao Jing (Han
dynasty, 1-2 century), the earliest pharmacopeia existing on
materia medica in China, some TCM ingredients such as
Yuan Zhi (Thinleaf milkwort), Ren Shen (Ginseng), Huang
Lian (Golden thread), and Long Yan (Longan) were recorded
to ameliorate the decline of people’s memory.
In this study, 27 ancient TCM books were selected, which
could be divided into 3 types, namely, Pharmacopoeias,
formulae monographs and renowned TCM doctor’s case
studies.
A database was established to determine the frequency
of herbs in these documents. Totally 236 formulae for
improving cognitive function were identiﬁed among 27
books mentioned above (Table 1); 139 herbs were gathered
from those 236 formulae and 10TCM herbs were prioritized
due to the highest frequency over 50 times (Table 2).
According to speciﬁcation documented in Chinese Phar-
macopeia [18], (i) Poria cocos is a diuretic with capacity to
invigorate spleen function and calm the mind. Clinically, it
is applicable for memory decline due to spleen deﬁciency
and phlegm blockage; (ii) Radix polygalae is able to anchor
the mind and eliminate the phlegm, and indicated in
forgetfulness and insomnia; (iii) Radix glycyrrhizae is a
qi tonic to invigorate the stomach and spleen, resolve
phlegm, and clear away heat and toxin; (iv) Radix Angelica
sinensis, as a vital blood tonic and antithrombotic agent,
is especially used to treat stroke and poststroke vascular
dementia induced by blood stasis; (v) Radix rehmanniae is
another tonic used to reinforce kidney essence and marrow.
Because of functionality to invigorate the energy, activate
blood circulation, or eliminate the toxin, these herbs can be
prescribed along or combined to exhibit a good therapeutic
eﬀect for senile dementia, for example, Zhi Ling Tang [19].
3.Evidence-BasedEfﬁcacy ofTCM Herbson
Cognitive Decline
3.1. Poria cocos. Poria cocos (Chinese name: Fu Ling) is the
dried sclerotium of the fungus, Poria cocos (Schw.) Wolf
(Fam. Polyporaceae).
3.1.1. Functionality/Eﬃcacy. T h e r ei ss u g g e s t i v ee v i d e n c e
that P. cocos is memory improving regardless of absence of
available clinical reports. Pharmacological research exhibited
that the water extract of P. cocos enhanced hippocampal
long-term potentiation (LTP) and improved scopolamine-
induced spatial memory impairment in rats ([20, 21],
Table 3).
3.1.2. Mechanism of Action. Its cognitive action has been
ascribed to slight cholinesterase (ChE) or acetylcholines-
terase (AChE) inhibition and bidirectional regulation on
cytosolic free calcium ([22–24], Table 3).
3.1.3.ActivePrinciples. Theresponsibleactivesforthecogni-
tive beneﬁts are unclear for the time being. Triterpene acids
and polysaccharides are principal constituents of P. cocos,
responsible for diverse bioactivities, including antitumor,
anti-inﬂammatory, nematicidal, antioxidant, antirejection,
antiemeticeﬀects,asinhibitorsagainstDNAtopoisomerases,
phospholipase A2. Besides, lecithin and choline present in
the fungus are beneﬁcially nutritional substance [25–29].
3.2. Radix polygalae. Radix polygalae is the root Polygala
tenuifolia Willd. or P. sibirica L. (Fam. Polygalaceae), usedEvidence-Based Complementary and Alternative Medicine 3
Table 1: TCM formulae selected from ancient Chinese documents.
Classiﬁcation Book name Dynasty Formulae
amount
Pharmacopoeia
Sheng Ji Zhong Lu Song (10–13 century) 45
Tai Ping Hui Min He Ji Ju Fang Song (10–13 century) 2
Tai Ping Sheng Hui Fang Song (10–13 century) 2
Pu Ji Fang Ming (14–17 century) 2
Yi Fang Lei Ju Ming (14–17 century) 2
Yi Zong Jin Jian Qing (17–19 century) 9
Formulae
monographs
Zhou Hou Fang Jin (3-4 century) 1
Qian Jin Yao Fang Tang (7–10 century) 3
Ren Zhai Zhi Zhi Fang Lun Song (10–13 century) 3
F uR e nD aQ u a nL i a n gF a n g Song (10–13 century) 1
Shi Zhai Bai Yi Xuan Fang Song (10–13 century) 5
Shi Yi De Jiu Fang Yuan (13-14 century) 4
Qi Xiao Liang Fang Ming (14–17 century) 29
Gu Jin Yi Jian Ming (14–17 century) 1
She Sheng Zhong Miao Fang Ming (14–17 century) 1
Zheng Zhi Bao Jian Qing (17–19 century) 1
Ji Yan Liang Fang Qing (17–19 century) 4
Medical edition Yan Yonghe’s medical edition Song (10–13 century) 13
Chen Wuze’s medical edition Song (10–13 century) 9
Dan Xi Xin Fa Yuan (13-14 century) 4
Shou Shi Bao Yuan Ming (14–17 century) 21
Jing Yue Quan Shu Ming (14–17 century) 21
Zheng Ti Lei Yao Ming (14–17 century) 2
Lei Zheng Zhi Chai Qing (17–19 century) 16
Bian Zheng Lu Qing (17–19 century) 16
Zha Bing Yuan Liu Xi Zhu Qing (17–19 century) 2
Yi Xue Zhong Zhong Can Xi Lu Modern (20 century) 7
Sum 236
Table 2: Top 10 memory-improving TCM herbs.
Chi name English name Latin name Part Plant Frequency
Fu Ling Poria Poria cocos Sclerotium Poria cocos (Schw.) Wolf 182
Ren Shen Ginseng Radix et rhizoma ginseng Root, stem Panax ginseng C. A. Mey. 169
Yuan Zhi Thinleaf milkwort Radix polygalae Root Polygala tenuifolia willd.
Polygala sibirica L. 139
Gan Cao Licorice Radix et rhizoma
glycyrrhizae Root, stem
Glycyrrhiza inﬂata Bat.
Glycyrrhiza uralensis Fisch.
Glycyrrhiza grabra L.
100
Dang Gui Chinese Angelica Radix Angelica sinensis Root Angelica sinensis (Oliv.)
Diels 84
Shi Chang Pu Grassleaf sweelﬂag rhizome Rhizoma acori tatarinowii Stem Acorus tatarinowii Schott. 80
Suan Zao Ren Spina date seed Semen ziziphi spinosae Seed
Ziziphus jujuba
Mill.var.spinosa. (Bunge)
Hu ex H.F. Chou
79
Shu Di Huang Prepared rehmannia root Radix rehmanniae Root Rehmannia glutinosa
Libosch. 62
Mai Dong Dwarf lilyturf tuber Radix ophiopogonis Root Ophiopogon japonicus (L.f.)
Ker-Gawl. 62
Sheng Jiang Fresh ginger Rhizoma zingiberis Stem Zingiber oﬃcinale Rosc. 53
(Note: data are cited from Pharmacopoeia of PR China 2005).4 Evidence-Based Complementary and Alternative Medicine
Table 3: Memory-improving and neuro-protective eﬀects of Poria cocos.
Test Test materials/dose Test model Endpoints/biomarkers Eﬀects Reference
In vivo
Extracts
20–100mg/kg Scopolamine-treated rats Eight-arm radial maze Improve spatial memory [20]
Extracts
250–500mg/kg Innate rats Electro-physiology
Spike amplitude Enhance hippocampal LTP [21]
Methanol extracts
200mg/mL Ellman ChE ChE activity Inhibit ChE by 27.8% [22]
Aqueous extracts
0.2mg/mL Innate ICR mice AChE activity Inhibit AChE by 13.9% [23]
In vitro Aqueous extracts
31–250μg/mL Brain neurons–neonatal rats Cytosolic [Ca2+] i Regulate bi-directly [Ca2+]i [ 24]
Long-term potentiation (LTP); choline esterase (ChE); acetylcholinesterase (AChE).
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Figure 1: Chemical structures of sinapic acid and tenuifolin.
as a cardiotonic and cerebrotonic, sedative and tranquilliser,
and for amnesia, neuritis, and insomnia [30, 31].
3.2.1. Functionality/Eﬃcacy. There is strong support that
thinleaf milkwort root is memory improving. BT-11, the
extract of dried root of Radix polygalae, was developed in
Korea as a functional diet with cognitive enhancing activity.
Elderly with subjective memory impairment and mild cog-
nitive impairment ascend with oral BT-11 at 300mg/d for
4–8 weeks. Except for mild dyspepsia, no adverse events were
reported [32, 33].
3.2.2. Mechanism of Action. A number of investigations also
sustained that Radix polygalae extracts functioned to pro-
mote neuronal proliferation and neurite outgrowth in nor-
mal brain and improve memory impaired by scopolamine,
stress, nucleus basalis magnocellularis-lesioning operation
via a variety of molecular pathways, including increasing
glucose utilization and inhibiting AChE activity. Besides
nootropic eﬀects, Radix polygalae extracts protected neurons
against insults induced by NMDA, glutamate, and Aβ ([34–
39], Table 4(a)). In addition, anti-inﬂammatory activity
probably contributed to the cognitive and neuroprotective
eﬃcacy, as Radix polygalae extracts inhibited interleukin-1
(IL-1)-mediated tumour necrosis factor (TNF)-α secretion,
and ethanol-induced IL-1 secretion by astrocytes [40, 41].
3.2.3. Active Principles. Phytochemically, Radix polygalae
mainly contains a variety of active constituents, including
saponins,xanthones,andacylatedoligiosaccharides[42–44].
Saponins, especially tenuifolin isolated from tenuigenin
might reinforce cognitive performance in aged and dysmne-
sia mice, via elevating levels of dopamine (DA) and nore-
pinephrine (NE), and inhibiting AChE activity (Figure 1).
Meanwhile, onjisaponin indicated cytoprotective activity in
PC12 cells, exposed to serum deﬁciency or glutamate. In
addition, tenuigenin facilitated memory in rats, damaged by
Aβ 1–40oribotenicacid,viaenhancingcholinergicfunction,
or inhibiting Aβ secretion ([45–48], Table 4(b)).
Few phytochemical principles have been isolated and
identiﬁed as CNS active components. Besides tenuifolin,
sinapic acid [49] ,ac o m m o nm o i e t yo ft e n u i f o l i s i d eBa n d
3, 6 -disinapoylsucrose, reversed memory deﬁcit induced
by scopolamine and basal forebrain lesion (Table 4(b),
Figure 1).
3.3. Radix et Rhizoma Glycyrrhizae. Radix et rhizoma gly-
cyrrhizae is the dried root and rhizome, generally derived
from a diﬀerent plant species, with similar properties,
including Glycyrrhiza uralensis Fisch., G. inﬂata Bat., or G.
glabra L. (Fam. Leguminosae).
3.3.1. Functionality/Eﬃcacy. The extracts of Radix gly-
cyrrhizaereversedthecognitivedeﬁcitsinducedbydiazepam,Evidence-Based Complementary and Alternative Medicine 5
Table 4
(a) Memory-improving and neuro-protective eﬀects of Radix polygalae
Test Test materials/dose Test model Endpoint/biomarkers Eﬀects Mechanisms Reference
Clinic Extracts
300mg/d, 4w
Healthy Korean elderly
with subjective memory
impairment and mild
cognitive impairment
double-blind,
placebo-controlled,
randomized, parallel study
Korean version of
California verbal
learning test
Self-ordered pointing
test
Improve verbal
memory
No adverse events,
except mild
dyspepsia
N.A. [32, 33]
In vivo
Extracts
i.p., 2mg/kg Innate rats Nestin/BrdU
Tuj1/BrdU
Improve memory
Promote
neuro-genesis
Promote
proliferation
Promote neurite
outgrowth
[34]
Extracts Stress-treated rats Glucose utilization
Cell adhesion molecule Improve memory
Increase glucose
utilization
Increase total
NCAM
[35]
Extracts
2g / k g ,1 – 3w NBM-lesioning rats Neurological test
Step-through test Improve memory N.A. [36]
Extracts
i.p., 10mg/kg Scopolamine-treated rats
Passive avoidance test
water maze test
AChE
Improve memory Inhibit AChE [36]
In vitro
Extracts
0.5–5μg/mL
Rat primary neurons
exposed to Glutamate or
Aβ
Cell viability Protect neurons N.A. [37]
Extracts
0.05–5μg/mL
Rat cerebellar granule
neurons exposed to NMDA
Glutamate release
(Ca2+)i/ROS Protect neurons N.A. [38]
Extracts
0.1–100μg/mL
Rat cortical neurons
exposed to Aβ 25–35
Axonal length
Neuro-ﬁlament-
H/MAP-2
Cell viability
Activate axonal
extension Protect
neurons
N.A. [39]
Acetylcholinesterase (AChE); bromodeoxyuridine (BrdU); microtubule-associated protein-2 (MAP-2); nucleus basalis magnocellularis (NBM); neural cell
adhesionmolecule(NCAM);N-methyl-D-asparticacid(NMDA);reactiveoxygenspecies(ROS);β amyloid(Aβ);notavailable(N.A.);intraperitoneally(ip.).
(b) Memory-improving and neuro-protective eﬀects of active components from Radix polygalae
Test Test materials/dose Test model Endpoints/biomarkers Eﬀects Mechanisms Reference
In vivo
Sinapic acid
10–100mg/kg
Scopolamine-treated
rats Radial maze test Improve memory N.A. [42, 43]
Sinapic acid
3–100mg/kg, 1h
Scopolamine-treat mice
Basal forebrain lesioning
mice
Step-through test
Ach/ChAT Improve memory N.A. [49]
Tenuifolin
20–80mg/kg, 15d
Aged mice Dysmnesia
mice
Step-down test
Y maze trial
AChE,NE,DA,5-HT
Improve memory
Increase NE and
DA
Inhibit AChE
[45]
Tenuigenin
18.5–74mg/kg
Aβ 1-40-treated rats
ibotenic acid-treated rats
Step-through test
AchE, ChAT Improve memory Cholinergic [46]
Acylated
oligosaccharides
1–10mg/kg
Scopolamine-treated
rats Step-through test Improve memory Cholinergic [44]
In vitro
Tenuigenin
1–4μg/mL
APP-transfected
SH-SY5Y cells
Fluorescence resonance
energy transfer Inhibit Aβ secretion Inhibit BACE1 [47]
Onjisaponin
10μM
Serum deﬁciency or
glutamate-treated PC12
cells
Cell survival Protect PC 12 cells N.A. [48]
Acetylcholine (Ach); acetylcholinesterase (AChE); choline acetyltransferase (ChAT); 5-hydroxytryptamine (5-HT); dopamine (DA); norepinephrine (NE);
beta-site APP cleaving enzyme (BACE); amyloid precursor protein (APP); β amyloid (Aβ); not available (N.A.).6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Chemical structures of isoliquiritigenin, liquiritigenin, and glabridin.
scopolamine, and beta-amyloid peptide 25–35 in mice at
doses of 75, 150, and 300mg/kg per oral, or diet containing
either 0.5 or 1% extract, through anti-AChE and antioxidant
activities. In addition, roasted licorice extracts elicited neu-
roprotection against brain damage after transient forebrain
ischemia in Mongolian gerbils, behind which antioxidant
activity was also implicated, for example, maintaining
superoxide dismutase (SOD)1 level in hippocampal CA1
pyramidal cells ([50–54], Table 5).
3.3.2. Mechanism of Action and Active Principles. Radix gly-
cyrrhizae contains glycyrrhizin, glycyrrhizic acid, glabridin
and derivatives, glabrol, glabrene, 17β-hydroxysteroid dehy-
drogenase, glucoliquiritin apioside, prenyllicoﬂavone A,
shinﬂavone, shinpterocarpin, 1-methoxyphaseollin, salicylic
acid, and derivatives, as well as other saponins, ﬂavonoid
glycosides, and ﬂavonoids.
Isoliquiritigenin, liquiritigenin, and glabridin have been
identiﬁedfromtheRadixglycyrrhizaetobepossiblebioactive
compounds ([55–58], Table 5, Figure 2).
(1) Isoliquiritigenin also has the protective potential
against transient middle cerebral artery occlusion-
inducedfocalcerebralischemiainrats,atthedosesof
5, 10, and 20mg/kg. Its protection may be attributed
to amelioration of cerebral energy metabolism and
antioxidant property.
(2) Liquiritigenin, a plant-derived highly selective estro-
gen receptor β agonist has been identiﬁed to alleviate
the cognitive recession in the elders.
(3) Glabridin appears to be an active isoﬂavone as it
improved learning and memory in mice at 1, 2,
and 4mg/kg, through targeting at ChE. Glabridin
had a protective eﬀect on cerebral ischemia injury,
and neuron insult induced by staurosporine at 5,
25mg/kg (i.p). Its underlying mechanism is probably
linked to antioxidant and antiapoptotic activity.
(4) Glabrene also could be beneﬁcial to memory due to
estrogen-like activities, like isoliquiritigenin, liquirit-
igenin, and glabridin [59–61].
3.4.RadixAngelicasinensis. RadixAngelicasinensis(Chinese:
Danggui, Dong quai, Donggui; Korean Danggwi), is the
dried root of Angelica sinensis (Oliv.) Diels (Umbelliferae).
3.4.1. Functionality/Eﬃcacy. Behaviour test displayed that
Radix Angelica sinensis extracts ameliorated scopolamine
and cycloheximide, but not p-chloroamphetamine-induced
amnesia at 1g/kg bw. In addition in vitro study showed
that Radix Angelica sinensis extracts prevented the neuro-
toxicity induced by Aβ in Neuro 2A cells, at the doses
ranging 25–200μg/mL, through antioxidant pathway ([62,
63], Table 6(a)). Furthermore, estrogenic activity of Angelica
sinensis will probably help alleviate peri- or postmenopausal
symptoms including cognitive decline in women [64, 65].
3.4.2. Mechanism of Action and Active Principles
(1) Ferulic acid has been identiﬁed to be an active prin-
ciple because it may reverse memory deﬁcits induced
by a variety of toxins, including dl-buthionine-(S,R)-
sulfoximine, trimethyltin, glutamate, Aβ1-42, scopo-
lamine, and cycloheximide. Multiple mechanisms
are probably implicated into its cognitive beneﬁts,
including inhibition on oxidative stress, activation of
ChAT or enhance the cholinergic activities, compet-
itive N-methyl-D-aspartate (NMDA) receptor antag-
onism, suppression on immunoreactivities of the
astrocyte, and facilitation of cerebral blood ﬂow
([66–70], Table 6(b), Figure 3).
(2) Z-ligustilide has been identiﬁed to be another active
component from volatile of Radix Angelica sinensis.
It may protect brain and cognition especially against
focal and global ischemia induced by permanent
common carotid arteries occlusion (CCAO) and
transient middle cerebral artery occlusion (MCAO)
[71–73], (Table 6(b), Figure 3).
(3) Additionally, N-methyl-beta-carboline-3-carboxam-
ide, Coniferyl ferulate, and 11-angeloylsenkyunolide
Fwereidentiﬁedtobeanti-ADcomponentsprobably
by inhibiting Aβ1-40 induced toxicity and AChE
activity ([62, 74], Figure 3).
3.5. Radix rehmanniae. Radix rehmanniae is the roots of
Rehmannia glutinosa Libosch., family Scrophulariaceae.
3.5.1. Functionality/Eﬃcacy. There have been growing evi-
dences that Radix rehmanniae extract possesses signiﬁcant
neuroprotective activity ([75, 76], Table 7).Evidence-Based Complementary and Alternative Medicine 7
Table 5: Memory-improving and neuro-protective eﬀects of Radix et rhizoma glycyrrhizae.
Test Test materials /dose Test model Endpoint/biomarkers Eﬀects Mechanisms Reference
In vivo
Extracts
75–300mg/kg, 7d
diet
0.5 or 1%, 6w
Diazepam treated mice Elevated plus-maze test Improve memory Cholinergic [50]
Scopolamine treated mice passive avoidance test [51]
Aβ 25–35 treated mice
passive avoidance test
Morris water-maze test
TBARS/Catalase/AChE
Improve memory Quench oxidative stress
Inhibit AChE [52]
Aqueous extracts
150mg/kg, 7d
n-hexane extracts
5mg/kg,3d
Innate mice AChE Inhibit AChE N.A. [53]
Methanol extract
50–100mg/kg, 21d
IR treated Mongolian
gerbils
Cu, Zn-SOD1
CA1 pyramidal cells Protect neurons Restore Cu, Zn-SOD1 [54]
Liquiritigenin
2.3–21mg/kg, 7d Aβ (25–35)-treated rats
Morris water maze test
Reference memory task
Probe task
Two-way shuttle
avoidance task
MAP, Nissle, Notch-2
[55]
In vivo
Isoliquiritigenin
5–20mg/kg, 7d MCAO-treated rats
MDA
SOD,GSH-Px, Catalase
Na+-K+-ATPase, ATP
Energy charge, total
adenine nucleotides
Protect brain
Promote energy
metabolism
Inhibit oxidative stress
[56]
Glabridin
1–4mg/kg, 3d Innate Mice ChE Improve memory Inhibit ChE [57]
Glabridin
5–25mg/kg
IR-treated rats
Staurosporine-treated
neurons
MDA, GSH and SOD
Bax, caspase-3,bcl-2 Protect neurons Inhibit apoptosis
Inhibit oxidative stress [58]
Acetylcholinesterase (AChE); cholinesterase (ChE); thiobarbituric acid-reactive substances (TBARS); superoxide dismutase (SOD); malondialdehyde (MDA);
glutathione (GSH); microtubule-associated protein (MAP) 2; middle cerebral artery occlusion (MCAO); β amyloid (Aβ); Ischemia-reperfusion (IR); not
available (N.A.).
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Figure 3: Chemical structures of ferulic acid, Z-ligustilide, N-methyl-beta-carboline-3-carboxamide, coniferyl ferulate, and 11-
angeloylsenkyunolide F.8 Evidence-Based Complementary and Alternative Medicine
Table 6
(a) Memory-improving and neuro-protective eﬀects of Radix Angelica sinensis
Test Test materials/dose Test model Endpoint/biomarkers Eﬀects Mechanisms Reference
In vivo Extracts
1g/kg
scopolamine-treated rats
cycloheximide-treated rats Step-through test Improve memory N.A. [62]
In vitro Extracts
25–200μg/ml Aβ-treated Neuro 2A cells MTT assay/ΔΨm
ROS/LPO/GSH Protect neurons Quench
oxidative stress [63]
3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazoliumbromide(MTT);Lipidperoxidation(LPO);mitochondrialtransmembranepotential(ΔΨm);βamyloid
(Aβ); glutathione (GSH); not available (N.A.).
(b) Memory-improving and neuro-protective eﬀects of active components from Radix Angelica sinensis
Test Test materials/dose Test model Endpoint/biomarkers Eﬀects Mechanisms Reference
In vivo
Ferulic acid
s.c., 5mg/kg/d, 6d
dl-buthionine-(S,R)-
Sulfoximine treated mice
Object recognition test
Oxidative carbonyl
protein
Improve memory Elevate carbonyl
protein [66]
Ferulic acid
28d Trimethyltin-treated mice
Y-maze test
Passive avoidance test
ChAT
Improve memory Activate ChAT [67]
Ferulic acid
i.p., 20–80mg/kg, 3d Glutamate-treated mice
Behavioral test
histopathology
[(3)H]-labeled
glutamate
bcl-2/caspase-3
Protect brain NMDA receptor
antagonist [68]
Ferulic acid
0.006%, 4w Aβ1-42-treated mice
Step-through test
Y-maze test
Water maze test
GFAP/IL-1 β
Improve memory
Protect brain
Suppress astrocytes
immunoreactivities [69]
Ferulic acid
50–100mg/kg
Scopolamine-treated rats
Cycloheximide-treated
rats
Step-through test Improve memory Cholinergic
Enhance CBF [70]
Z-ligustilide
10–40mg/kg, 4w CCAO-treated rats
Morris water maze
Neurons/astrocytes
count
MDA/SOD/ChAT/AChE
Improve memory
Inhibit oxidative
stress
Cholinergic
[71]
Z-ligustilide
20–80mg/kg MCAO-treated rats
TTC staining
Brain swelling
Behavioural score
Protect brain N.A. [72]
Z-ligustilide
5–20mg/kg IR-treated ICR mice
TTC staining
MDA/GSH-Px/SOD
Bcl-2/Bax/caspase-3
Protect brain
Inhibit oxidative
stress
Inhibit apoptosis
[73]
Choline acetyltransferase (ChAT); cerebral blood ﬂow (CBF); glial ﬁbrillary acidic protein (GFAP); interleukin-1 (IL-1); glutathione peroxidase (GSH-
PX); 2,3,5-triphenyltetrazolium chloride (TTC); subcutaneously (s.c.); ischemia-reperfusion (IR); superoxide dismutase (SOD); malondialdehyde (MDA);
acetylcholinesterase (AChE); common carotid arteries occlusion (CCAO); middle cerebral artery occlusion (MCAO); β amyloid (Aβ); N-methyl-D-aspartate
(NMDA); not available (N.A.).
OH
OH
OH
H
H
H
O
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Figure 4: Chemical structure of catalpol.
3.5.2. Mechanism of Action. Radix rehmanniae extract im-
proved learning and memory in rats with Monosodium-
glutamate-(MSG-) injured thalamic arcuate nucleus at
4.5, and 9.0g/kg, through adjusting glutamates and γ-
amiobutyic acid (GABA) levels, as well as increasing the
expression of hippocampal c-fos, nerve growth factor
(NGF), NMDA receptor 1, and GABA receptor. Moreover,
Rehmanniaextractstimulatedglialcell-derivedneurotrophic
factor (GDNF) gene expression in C6 glioblastoma cells,
through upregulating cPKC and ERK 1/2 pathways ([76, 77],
Table 7).
3.5.3. Active Components. Catalpol, an iridoid glycoside,
was isolated from the fresh Radix rehmanniae. It exists
broadly in many plants all over the world and has many
biological functions such as anti-inﬂammation, promoting
of sex hormones production, protection of liver damage, and
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Table 7: Memory-improving and neuro-protective eﬀects of Radix rehmanniae.
Test Test materials/dose Test model Endpoint/biomarkers Eﬀects Mechanisms Reference
In vivo
Extracts
4.5–9.0g/kg MSG-treated rats
Morris maze test
Step-down test
c-fos, NGF expression
Improve memory Motivate hippocampal
c-fos /NGF expression [75]
Extracts
4.5–9.0g/kg MSG-treated rats
Morris maze test
Step-down test
NMDA-R1, GABA-R
Glutamine, GABA
levels
Improve memory
Motivate hippocampal
NMDA-R1/GABA-R
expression
adjust Glutamine/GABA
levels
[77]
In vitro Extracts
0.1–1.0mg/mL, 1–3d C6 glioblastoma cells GDNF gene expression Stimulate GDNF
expression
Up-regulate
cPKC/ERK1/2 pathways [76]
In vivo
Catalpol
i . p . ,1 0m g / k g ,1 0d LPS-treated mice MMP
NF-κB
Improve memory
Inhibit inﬂammation
Inhibit NF-κB activation
protect mitochondrial
function
[78]
Catalpol
2.5–10mg/kg, 2w
D-galactose-treated
mice
Passive avoidance test
LDH, GSH-ST, GS, CK Improve memory
Inhibit oxidative stress
Maintain energy
metabolism
[79–81]
Catalpol
i.p., 1–10mg/kg IR-treated Gerbils Bcl-2, Bax, NO Protect CA1 neurons
Improve memory
Inhibit apoptosis
Inhibit oxidative stress
[82–84]
Catalpol
i.p., 5mg/kg, 10d Aged rats GAP-43/synaptophysin
PKC, BDNF
Protect
neuroplasticity
Up-regulate PKC and
BDNF (hippocampus) [85]
In vitro
Catalpol
0.5 mM, 1h
MPTP-treated
neurons
Cells Viability,
MAO-B,
ROS, MCI, MMP, MPT
Protect neurons
Protect mitochondria
Maintain MAO-B
activity
[86]
Catalpol
0.5mM, 30min
Aβ1-42-treated
Cortical neurons-glia
Cells Viability
TNF-α, iNOS, NO,
ROS
Protect neurons Inhibit inﬂammation [87]
Catalpol
0.25–5mg/ml
Primary rat cortical
neurons
Cells Viability
NF-200 antigen
Enhance axonal
growth
No impact on survival
N.A. [88]
Catalpol
0.1–100μg/ml
OGD-treated PC12
cells
Bcl-2, caspase-3/MMP
SOD, GSH-Px Inhibit apoptosis
Retain Bcl-2 and MMP
suppress caspase-3
activation
maintain SOD and
GSH-Px
[89]
Catalpol
0.1–1.0mM
H2O2-treated PC12
cells
Bcl-2
c y t o c h r o m ecc a s p a s e
Protect neurons
Inhibit apoptosis
Prevent cytochrome c
release
Inactivate caspase
cascade
[90]
Catalpol
0.05–0.5mM
H2O2-treated
astrocytes
Cells Viability
ROS Inhibit oxidative stress maintain glutathione
Scavenge ROS
[91]
Catalpol
0.3–275.9μM, 24h
OGD-treated mice
astrocytes
Cell survival/MMP
ROS, NO, iNOS, MDA
SOD, GSH-Px, GSH
Protect astrocytes Inhibit oxidative stress [92]
Nerve growth factor (NGF); oxygen-glucose deprivation (OGD); lactate dehydrogenase (LDH); glutathione S-transferase (GSH-ST); glutamine synthetase
(GS); creatine kinase (CK); mitochondrial complex I (MCI); mitochondrial membrain potential (MMP); mitochondrial permeability transition (MPT);
brain-derived neurotrophic factor (BDNF); γ-amiobutyic acid (GABA); lactate dehydrogenase (LDH); nitric oxide (NO); inducible nitric oxide synthase
(iNOS); nuclear factor-kappa B (NF-κB); protein kinase C (PKC); 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); monosodium glutamate (MSG);
lipopolysaccharide(LPS);ischemia-reperfusion(IR);monoamineoxidase(MAO);tumournecrosisfactor(TNF)-α;reactiveoxygenspecies(ROS);superoxide
dismutase (SOD); malondialdehyde (MDA); glutathione (GSH); glutathione peroxidase (GSH-Px); glial cell-derived neurotrophic factor (GDNF).
Recently, catalpol has been identiﬁed as a vital active
with robust cognitive potential (Figure 4). Behaviour studies
exhibited that catalpol reversed brain damage and mem-
ory deﬁcits in mice induced by lipopolysaccharide (LPS)
and D-galactose and in gerbils by cerebral ischemia. The
nootropic and neuroprotective eﬃcacy of catalpol probably
resulted from a variety of underlying molecular mechanisms
(Table 7).
(i) Antioxidant activity: catalpol promoted endogenous
antioxidant enzyme activities, superoxide dismutase
(SOD) and glutathione peroxidase (GSH-Px), and10 Evidence-Based Complementary and Alternative Medicine
antioxidant glutathione (GSH), cut down malondi-
aldehyde (MDA) and reactive oxygen species (ROS)
generation in PC12 cells and astrocytes primary
cultures, exposed to oxygen and glucose deprivation
or H2O2, and in senescent mice induced by D-
galactose [79–81, 86, 89, 91, 92].
(ii) Anti-inﬂammatory activity: catalpol signiﬁcantly
reducedthereleaseofROS,TNF-α,nitricoxide(NO)
and inducible nitric oxide synthase (iNOS) expres-
sion after Aβ (1–42)-induced microglial activation
in primary cortical neuron-glia cultures, and LPS-
induced nuclear factor-kappa B (NF-κB) activation
in mice [78, 87].
(iii) Neurogenetic activity: catalpol can enhance axonal
growthofcorticalneuronsculturedinvitrofrom24h
newly born rat, at 1–5mg/mL and ameliorate age-
related presynaptic proteins decline (synaptophysin
and GAP-43), and neuroplasticity loss in the hip-
pocampus of the aged rats, by upregulating protein
kinase C (PKC) and brain-derived neurotrophic
factor (BDNF) [85, 88].
(iv) Antiapoptotic activity: catalpol not only suppressed
the downregulation of Bcl-2, upregulation of Bax,
and the release of mitochondrial cytochrome c to
cytosol, but also attenuated caspase-3 activation,
poly-ADP-ribose polymerase (PARP) cleavage, and
eventuallyprotectedagainstH2O2-inducedapoptosis
inPC12cellsandintheischemicdorsalhippocampus
of gerbils subject to CCAO [82–84, 90].
(v) In addition, the function to stimulate the production
of adrenal cortical hormones, which increases the
production of sex hormones, is likely implicated
into the cognitive beneﬁt of catalpol in menopausal
women [92].
4. Discussion and Conclusion
TCM has a long history of human use for mental health.
The current literature survey addressing traditional evidence
from human studies has been primarily carried out. The
top 10 TCM herb ingredients were identiﬁed. Poria, thinleaf
milkwort, licorice, Chinese Angelica, and Rehmannia were
further prioritized to have the highest potential beneﬁt to
dementia intervention, due to their highest frequency of use
in 236 formulae collected from 29 ancient Pharmacopoeias,
ancient formula books, or historical archives on ancient
renowned TCM doctors, over the past 10 centuries.
In TCM philosophy, AD is assumed to be induced by
kidney essence vacuity and toxin (turbid phlegm). The
amnestic mild cognitive impairment in elderly population
has been disclosed in a clinical investigation to correlate with
kidney essence vacuity and turbid phlegm blocking upper
oriﬁces. The whole cognitive function may worsen because
of the aggravation of kidney essence vacuity, deﬁciency of
blood and qi, phlegm and heat toxin and may eventually lead
to multiple cognitive domains impairment, even dementia
[93].
Based on the history of use, there is strong clinical
support that Radix polygalae is memory improving since its
eﬃcacyhasbeendemonstratedinelderlywithmildcognitive
decline [32, 33]. There is suggestive evidence that Poria
cocos, Radix glycyrrhizae, Radix Angelica sinensis,o rRadix
rehmanniae are memory improving, though modern clinical
reports concerning the four herbs are absent yet.
Furthermore, pharmacological investigations in 39 ani-
mal studies and 18 in vitro studies also indicated that
the ﬁve ingredients can elicit memory-improving eﬀects
via multiple mechanisms of action, covering estrogen-like,
cholinergic, antioxidant, anti-inﬂammatory, antiapoptotic,
Neurogenetic, and anti-Aβ activities. These mechanisms are
in well accordance with modern pharmacotherapy for AD
and VD, by prescribing ChEIs, anti-inﬂammatory medi-
ations, antioxidants, estrogen, neurotrophic factors, and
nootropics, depending on diﬀerence situations.
In the meantime, 11 active molecules have also been
identiﬁed, including sinapic acid, tenuifolin, isoliquiriti-
genin, liquiritigenin, glabridin, ferulic acid, Z-ligustilide,
N-methyl-beta-carboline-3-carboxamide, coniferyl ferulate
and 11-angeloylsenkyunolide F, and catalpol. Most of them
are lipophilic compounds with comparatively low-molecular
weight (200 ∼ 700) and likely to be absorbed into blood
and distributed to brain according to Lipinski rule of 5 [94].
The 11 compounds can serve as active markers for charac-
terisation and standardization of corresponding TCM herbal
extracts and pharmacokinetics markers for bioavailability
study. In drug discovery, these phyto-chemicals can also be
used as candidates to optimize derivatives [95].
Taken together, it is concluded that TCM could have
a complementary and alternative role in preventing and
treating cognitive disorder in the elderly. The scientiﬁc
evidence is being continuously mined to back up the
traditional medical wisdom and product innovation in the
healthcare sectors.
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